Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
598 | 3264 | 34.6 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
498 | 3 | PHEOCHROMOCYTOMA//NEUROBLASTOMA//WILMS TUMOR | 22561 |
1899 | 2 | NEUROBLASTOMA//ALVEOLAR SOFT PART SARCOMA//MYCN | 5933 |
598 | 1 | NEUROBLASTOMA//MYCN//MYCN AMPLIFICATION | 3264 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEUROBLASTOMA | authKW | 3825964 | 45% | 28% | 1476 |
2 | MYCN | authKW | 966452 | 6% | 55% | 188 |
3 | MYCN AMPLIFICATION | authKW | 317278 | 1% | 81% | 42 |
4 | N MYC | authKW | 245227 | 3% | 31% | 84 |
5 | HIGH RISK NEUROBLASTOMA | authKW | 179575 | 1% | 80% | 24 |
6 | N MYC AMPLIFICATION | authKW | 116912 | 0% | 83% | 15 |
7 | NEUROBLASTIC TUMORS | authKW | 95767 | 0% | 64% | 16 |
8 | STAGE 4 | authKW | 95650 | 0% | 68% | 15 |
9 | ITALIAN NEUROBLASTOMA FDN | address | 89787 | 0% | 80% | 12 |
10 | INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION | authKW | 75760 | 0% | 90% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 47718 | 62% | 0% | 2019 |
2 | Pediatrics | 17735 | 26% | 0% | 842 |
3 | Hematology | 2920 | 10% | 0% | 320 |
4 | Pathology | 1688 | 7% | 0% | 230 |
5 | Genetics & Heredity | 1412 | 10% | 0% | 324 |
6 | Surgery | 669 | 10% | 0% | 320 |
7 | Cell Biology | 383 | 8% | 0% | 248 |
8 | Medical Laboratory Technology | 103 | 1% | 0% | 39 |
9 | Transplantation | 80 | 1% | 0% | 47 |
10 | Radiology, Nuclear Medicine & Medical Imaging | 51 | 3% | 0% | 94 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROBLASTOMA | 142562 | 1% | 61% | 25 |
2 | ITALIAN NEUROBLASTOMA FDN | 89787 | 0% | 80% | 12 |
3 | BIOCHEM INNOVAT CANC THER EUT | 69291 | 1% | 44% | 17 |
4 | PEDIAT ONCOL HEMATOL | 62220 | 3% | 8% | 86 |
5 | CHILDRENS CANC | 57337 | 2% | 8% | 78 |
6 | TUMOR GENET B030 | 54109 | 0% | 64% | 9 |
7 | GENET BIOL CANC | 52032 | 0% | 35% | 16 |
8 | UNIDAD ONCOL PEDIAT | 50034 | 1% | 31% | 17 |
9 | TUMOR GENET | 47917 | 1% | 18% | 29 |
10 | PEDIAT ONCOL | 44019 | 5% | 3% | 161 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEDICAL AND PEDIATRIC ONCOLOGY | 74295 | 4% | 6% | 141 |
2 | PEDIATRIC BLOOD & CANCER | 32739 | 4% | 3% | 126 |
3 | JOURNAL OF PEDIATRIC SURGERY | 16972 | 5% | 1% | 161 |
4 | GENES CHROMOSOMES & CANCER | 15631 | 2% | 2% | 73 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 11148 | 4% | 1% | 140 |
6 | EUROPEAN JOURNAL OF CANCER | 10605 | 3% | 1% | 107 |
7 | AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 9019 | 1% | 3% | 31 |
8 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 8297 | 2% | 2% | 57 |
9 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 6245 | 1% | 2% | 37 |
10 | CANCER | 5740 | 4% | 0% | 132 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEUROBLASTOMA | 3825964 | 45% | 28% | 1476 | Search NEUROBLASTOMA | Search NEUROBLASTOMA |
2 | MYCN | 966452 | 6% | 55% | 188 | Search MYCN | Search MYCN |
3 | MYCN AMPLIFICATION | 317278 | 1% | 81% | 42 | Search MYCN+AMPLIFICATION | Search MYCN+AMPLIFICATION |
4 | N MYC | 245227 | 3% | 31% | 84 | Search N+MYC | Search N+MYC |
5 | HIGH RISK NEUROBLASTOMA | 179575 | 1% | 80% | 24 | Search HIGH+RISK+NEUROBLASTOMA | Search HIGH+RISK+NEUROBLASTOMA |
6 | N MYC AMPLIFICATION | 116912 | 0% | 83% | 15 | Search N+MYC+AMPLIFICATION | Search N+MYC+AMPLIFICATION |
7 | NEUROBLASTIC TUMORS | 95767 | 0% | 64% | 16 | Search NEUROBLASTIC+TUMORS | Search NEUROBLASTIC+TUMORS |
8 | STAGE 4 | 95650 | 0% | 68% | 15 | Search STAGE+4 | Search STAGE+4 |
9 | INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION | 75760 | 0% | 90% | 9 | Search INTERNATIONAL+NEUROBLASTOMA+PATHOLOGY+CLASSIFICATION | Search INTERNATIONAL+NEUROBLASTOMA+PATHOLOGY+CLASSIFICATION |
10 | INRG | 66511 | 0% | 89% | 8 | Search INRG | Search INRG |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | IRWIN, MS , PARK, JR , (2015) NEUROBLASTOMA PARADIGM FOR PRECISION MEDICINE.PEDIATRIC CLINICS OF NORTH AMERICA. VOL. 62. ISSUE 1. P. 225 -+ | 129 | 65% | 22 |
2 | BRODEUR, GM , (2003) NEUROBLASTOMA: BIOLOGICAL INSIGHTS INTO A CLINICAL ENIGMA.NATURE REVIEWS CANCER. VOL. 3. ISSUE 3. P. 203-216 | 107 | 66% | 1094 |
3 | WESTERMANN, F , SCHWAB, M , (2002) GENETIC PARAMETERS OF NEUROBLASTOMAS.CANCER LETTERS. VOL. 184. ISSUE 2. P. 127-147 | 122 | 87% | 104 |
4 | OWENS, C , IRWIN, M , (2012) NEUROBLASTOMA: THE IMPACT OF BIOLOGY AND COOPERATION LEADING TO PERSONALIZED TREATMENTS.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 49. ISSUE 3. P. 85 -115 | 157 | 55% | 12 |
5 | MARIS, JM , HOGARTY, MD , BAGATELL, R , COHN, SL , (2007) NEUROBLASTOMA.LANCET. VOL. 369. ISSUE 9579. P. 2106-2120 | 94 | 51% | 770 |
6 | BOWN, N , (2001) NEUROBLASTOMA TUMOUR GENETICS: CLINICAL AND BIOLOGICAL ASPECTS.JOURNAL OF CLINICAL PATHOLOGY. VOL. 54. ISSUE 12. P. 897 -910 | 117 | 85% | 79 |
7 | BRODEUR, GM , PRITCHARD, J , BERTHOLD, F , CARLSEN, NLT , CASTEL, V , CASTLEBERRY, RP , DEBERNARDI, B , EVANS, AE , FAVROT, M , HEDBORG, F , ET AL (1993) REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT.JOURNAL OF CLINICAL ONCOLOGY. VOL. 11. ISSUE 8. P. 1466 -1477 | 77 | 74% | 1095 |
8 | BOSSE, KR , MARIS, JM , (2016) ADVANCES IN THE TRANSLATIONAL GENOMICS OF NEUROBLASTOMA: FROM IMPROVING RISK STRATIFICATION AND REVEALING NOVEL BIOLOGY TO IDENTIFYING ACTIONABLE GENOMIC ALTERATIONS.CANCER. VOL. 122. ISSUE 1. P. 20 -33 | 67 | 58% | 9 |
9 | VAN ROY, N , DE PRETER, K , HOEBEECK, J , VAN MAERKEN, T , PATTYN, F , MESTDAGH, P , VERMEULEN, J , VANDESOMPELE, J , SPELEMAN, F , (2009) THE EMERGING MOLECULAR PATHOGENESIS OF NEUROBLASTOMA: IMPLICATIONS FOR IMPROVED RISK ASSESSMENT AND TARGETED THERAPY.GENOME MEDICINE. VOL. 1. ISSUE . P. - | 87 | 69% | 16 |
10 | NORMAND, C , MICHON, J , JANOUEIX-LEROSEY, I , DELATTRE, O , SCHLEIERMACHER, G , (2011) GENETIC ALTERATIONS IN NEUROBLASTOMA AND THEIR USEFULNESS FOR CLINICAL MANAGEMENT.BULLETIN DU CANCER. VOL. 98. ISSUE 5. P. 477 -488 | 64 | 91% | 1 |
Classes with closest relation at Level 1 |